Basic Information
Basic information for MIR9-3HG-214-29aa
Peptide Name MIR9-3HG-214-29aa
Genome Position chr15:89397341-89397427[+]
Species Human
Peptide Sequence MCLERKTSQSRRVRVPRSALATPTSSLKE
Peptide Length 29
Unique No (MIR9-3HG-201-29aa,MIR9-3HG-212-29aa,MIR9-3HG-213-29aa,MIR9-3HG-218-29aa-2,MIR9-3HG-219-29aa,MIR9-3HG-220-29aa,MIR9-3HG-221-29aa,MIR9-3HG-222-29aa,MIR9-3HG-226-29aa,MIR9-3HG-227-29aa,MIR9-3HG-233-29aa,MIR9-3HG-241-29aa,MIR9-3HG-246-29aa,MIR9-3HG-247-29aa-2,MIR9-3HG-251-29aa,MIR9-3HG-252-29aa,MIR9-3HG-253-29aa)
Grand Average of Hydropathicity -0.769
Relative Molecular Mass 3793.34
Experimental Evidences 1:ribo
lncRNA ID/Name ENSG00000255571;MIR9-3HG
Transcript ID/Name ENST00000654184;MIR9-3HG-214
Transcript Length 4201
Coding Ability 0.5163
DNA Sequence Corresponding to Peptide ATGTGTCTGGAGAGAAAGACATCACAGAGCAGAAGAGTGCGGGTGCCCAGGAGTGCACTTGCCACCCCTACTTCATCCCTGAAAGAG
Experimental Evidences
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :